weight loss drug news today glp-1 october 2025 As the use of medications continues to rise, researchers are exploring their potential impact on eye health. While these drugs can help manage diabetes and promote loss, recent studies suggest GLP-1 Trends: Costs & Coverage
Description
#Medicare #GLP1 #HealthcareNews #PublicHealth #HealthcarePolicy #ObesityCare #DiabetesCare #Healthcare360Magazine To view or add a comment, sign in A new editorial in JAMA raises good questions about the Medicare Bridge program

No transdermal GLP-1 patch is approved by the Food and Drug Administration for weight loss, and that matters, because approval is what verifies a product actually contains what it claims, at the dose it claims, and does what it says

and AstraZeneca PLC provide strong alternatives, focusing on expanding their respective portfolios of GLP-1 receptor agonists to treat type 2 diabetes and other related conditions
[DOI] [PMC free article] [PubMed] [Google Scholar] 39.Inflammatory links between obesity and metabolic disease
This helps you rotate sites and avoid irritation

When determining which companies made our list, we considered factors such as: Whether care was provided by a board-certified physician with weight-management experience Whether brand-name GLP-1 medications were available Whether nutritional guidance was provided Whether the fee structure was transparent Whether an insurance concierge service was provided in cases where the company did not accept health insurance The experts we consulted include: Jennifer Bourgeois, PharmD Rachel Pessah-Pollack, MD Sue Decotiis, MD Holly Lofton, MD Pichamol Jirapinyo, MD, MPH Michelle Pearlman, MD Monica Amin, PharmD As a registered dietitian with three years of experience working in a bariatric surgery clinic, Ive worked extensively with patients taking GLP-1 medications
